Abstract
In the progression of repetitive balloon inflations during percutaneous transluminal coronary angioplasty (PTCA), the heart becomes more tolerant to ischemia. The study reported here analyzed the effects of theophylline and nicorandil on this intriguing phenomenon. Twenty-one patients with stable angina pectoris due to a significant stenosis at the left anterior descending; artery were subjected to PTCA. The balloon was inflated twice for two minutes each with a three-minute reperfusion period. Theophyylline, an adenosine receptor antagonist, was intravenously administered (0.6mg/kg/hr) to six patients during PTCA (theophylline group). Nicorandil, a hybrid between nitrate and an ATP-sensitive potassium channel opener, was intravenously administered (6 mg/hr) to nine patients during PTCA (nicorandil group). The rest of the patients served as controls (ischemic preconditioning group, n = 6). Cardiac adaptation to the second ischemia was observed in the ischemic preconditioning group, judging from lactate metabolism and electrocardiography. In both the theophylline and nicorandil groups, the difference between the two ischemic events was abolished. In the nicorandil group, the severity of the first ischemia was less than that of the ischemic preconditioning group. In conclusion, signal transduction through the adenosine receptor and opening of the ATP-sensitive potassium channels might play key roles, interactively or independently, in the cardioprotection observed in the process of PTCA.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Murry CE, Jennings RB, Reimer KA. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136.
Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Hemann HC, Laskey WK. 1990, Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 82:2044–2051.
Murry CE, Jennings RB, Reimer KA. 1991. New insights into potential mechanisms of ischemic preconditioning. Circulation 84:442–445.
Ely SW, Berne RM. 1992. Protective effects of adenosine in myocardial ischemia. Circulation 85:893–904.
Berne RM. 1980, The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807–813.
Liu GS, Thornton JD, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. 1991. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350–356.
Tuchida A, Miura T, Miki T, Shimamoto K, Iimura O. 1992. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 26:456–461.
Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. 1993. Ischemic preconditioning increases adehosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Circulation 87:208–215.
Okazaki Y, Kodama K, Sato H, Kitakaze M, Hirayama A, Mishima M, Hori M, Inoue M. 1993. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol 21:1597–1604.
Tomai F, Crea F, Gaspardone A, Versaci F, Paulis RD, De Paulis R, Polisca P, Chiariello L, Gioffré PA. 1996. Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J 17:846–853.
Gross GS, Auchambach JA. 1992. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223–233.
Tomai F, Crea F, Gaspardone A, Versaci F, Paulis RD, de Peppo AP, Chiariello L, Gioffré PA. 1994. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K channel blocker. Circulation 90:700–705
Taira N. 1989. Nicorandil as a hybrid between nitrates and potassium channel opener. Am J Cardiol 63:18J–24J.
Hashimura K, Kijima Y, Matsu-ura Y, Ueda T, Kato Y, Mori I, Minamino T, Kitakaze M, Hori M. 1997. Effect of theophylline on adaptation of the heart to myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with stable angina pectoris. Am J Cardiol 79:475–477.
Kerensky RA, Kutcher MA, Braden GA, Applegate RJ, Solis GA, Little WC. 1995. The effects of intracoronary adenosine on preconditioning during coronary angioplasty. Clin Cardiol 18:91–96.
Kirsch GE, Codina J, Birnbaumer L, Brown AM. 1990. Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 259:H820–H826.
Kijima Y, Hashimura K, Matsuura Y, Kato Y, Ueda T, Yasuda T, Mori I. 1996. Nicorandil pharmacologically preconditions human heart to ischemia during coronary balloon angioplasty. J Mol Cell Cardiol 28:A319.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Kluwer Academic Publishers
About this chapter
Cite this chapter
Ueda, T. et al. (1998). Pharmacological Modification of Ischemic Preconditioning During Percutaneous Transluminal Coronary Angioplasty. In: Mochizuki, S., Takeda, N., Nagano, M., Dhalla, N.S. (eds) The Ischemic Heart. Progress in Experimental Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-39844-0_26
Download citation
DOI: https://doi.org/10.1007/978-0-585-39844-0_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8105-1
Online ISBN: 978-0-585-39844-0
eBook Packages: Springer Book Archive